Dr. Reddy's Laboratories Limited (RDY) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 |
|---|
| Cash from Operations | 15.44B | 10.91B | 15.57B | 14.63B | 22B | 6.62B | 9.32B | 8.5B | 136.19M | 53.15M | 17.93B | 11.25B | 19.68B | 23.26B | 9.28B | 6.66B | 9.12B | 17.33B | 5.11B | -3.45B |
| Operating CF Margin % | 20.22% | 12.5% | 17.69% | 17.12% | 25.86% | 7.92% | 11.62% | 11.07% | 0.19% | 0.07% | 2154.05% | 16.7% | 2570.15% | 34.36% | 1174.65% | 12.76% | 1261.99% | 32.58% | 656.42% | -7.01% |
| Operating CF Growth % | -29.82% | 64.77% | 67.16% | 72.19% | 16050.72% | 12354.31% | -48.03% | -24.48% | -99.31% | -99.77% | 93.15% | 69.05% | 115.78% | 34.21% | 81.77% | 293.01% | 5843.57% | 29548.29% | -44.82% | -131.6% |
| Net Income | 2.24B | 11.9B | 14.27B | 14.1B | 15.87B | 14.04B | 13.41B | 13.92B | 157.4M | 165.6M | 14.8B | 14.03B | 25.01B | 12.47B | 11.13B | 11.88B | 875M | 7.07B | 9.92B | 5.71B |
| Depreciation & Amortization | 5.66B | 5.21B | 5.05B | 4.76B | 4.55B | 4.72B | 3.98B | 3.81B | 44.7M | 45.28M | 3.79B | 3.57B | 3.06B | 3.27B | 3.13B | 3.05B | 2.96B | 2.98B | 2.98B | 2.9B |
| Stock-Based Compensation | 0 | 20M | 100M | 112M | 113M | 103M | 107M | 101M | 0 | 0 | 103M | 108M | 21M | 113M | 117M | 146M | 141M | 161M | 143M | 147M |
| Deferred Taxes | 0 | 3.53B | 4.08B | 4.95B | 4.18B | 4.7B | 5.75B | 4.9B | 0 | 0 | 4.33B | 4.44B | 3.66B | 3.88B | 4.98B | 2.78B | 1.61B | 2.64B | 2.76B | 1.72B |
| Other Non-Cash Items | -239.42M | -1.63B | -5.37B | -1.1B | -3.31B | -7.3B | -6.15B | -1.09B | -32.65M | -14.66M | -7.71B | -2.72B | -14.55B | -1.14B | -289M | -4.62B | 18.2B | -10.7B | -3.76B | -1.85B |
| Working Capital Changes | 7.78B | -8.13B | -2.56B | -8.19B | 584M | -9.65B | -7.78B | -13.14B | -33.26M | -143.06M | 2.61B | -8.17B | 2.48B | 4.67B | -9.78B | -6.57B | -14.66B | 15.18B | -6.95B | -12.07B |
| Change in Receivables | 3.57B | -2.35B | -2.88B | -4.81B | 1.75B | -7.85B | -3.4B | -786M | -23.12M | -106.83M | 7.34B | -4.65B | 2.49B | 1.91B | -3.71B | -6.44B | -4.14B | 6.16B | -7.55B | -11.48B |
| Change in Inventory | 1.91B | -2.16B | -2.04B | -6.15B | -363M | -1.06B | -5.01B | -6.32B | -47.05M | -62.47M | -4.7B | -4.64B | -4.21B | -1.64B | 2.77B | -926M | -14.18B | 8.55B | 1.07B | -5.36B |
| Change in Payables | -4.69B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -18.13M | 4.5M | 0 | 4.65B | -2.49B | 0 | 3.71B | 6.44B | 0 | 0 | 0 | 0 |
| Cash from Investing | -28.22B | -10.29B | -9.54B | -19.19B | -13.3B | -5.46B | -19.07B | -20.25B | -142.11M | -198.76M | -4.52B | -8.24B | -15.77B | -26.41B | 5.73B | -4.92B | -21.99B | -2.76B | 3.97B | -5.61B |
| Capital Expenditures | -11.29B | -6.7B | -5.22B | -6.86B | -7.66B | -7.2B | -7.54B | -5.11B | -75.78M | -60.21M | -3.68B | -12.17B | -3.75B | -3.1B | -3.33B | -8.69B | -4.03B | -4.47B | -3.58B | -3.2B |
| CapEx % of Revenue | 14.79% | 7.68% | 5.93% | 8.03% | 9.01% | 8.61% | 9.4% | 6.66% | 0.11% | 0.08% | 442.68% | 18.06% | 489.29% | 4.58% | 421.33% | 16.66% | 557.3% | 8.41% | 460.37% | 6.5% |
| Acquisitions | -3.17B | 0 | 0 | -51M | -1.66B | 0 | -51.76B | 0 | 633.69K | 6.31M | 0 | 12.17B | 0 | 0 | 0 | 0 | -326M | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 1.08B | -105M | -4.64B | -2.42B | -2.22B | -485M | 1.09B | -668M | -139 | -968 | 915M | -11.79B | 248M | 169M | 180M | 262M | 380M | 298M | -416M | 160M |
| Cash from Financing | 8.74B | 7.78B | -5.32B | -1.2B | -7.37B | 590M | 16.15B | 9.54B | 1.7M | 70.75M | -7.04B | -1.48B | -4.3B | 583M | -12.35B | -10.8B | 5.1B | -2.57B | -7.21B | 2.26B |
| Debt Issued (Net) | 9.04B | 8.68B | 2.37B | -256M | -5.15B | 1.52B | 16.55B | 10.27B | 4.5M | 74.66M | -587M | -991M | -4.13B | 1.09B | -7.07B | -10.29B | 5.4B | -2.2B | -2.93B | 2.46B |
| Equity Issued (Net) | 81.68M | 30M | 92M | 196M | -8.43B | 25M | 7.19B | 19M | 369.44K | 73.53K | 686M | 79M | 221M | 81M | 35M | 31M | 8M | 45M | 134M | 147M |
| Dividends Paid | 41.14M | 0 | -6.66B | 0 | 0 | 0 | -6.66B | 0 | 44.06K | 306.57K | -6.65B | 0 | 0 | 0 | -4.98B | 0 | 0 | 0 | -4.15B | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | -1.39B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -428.84M | -936M | -1.12B | -1.14B | 6.21B | -956M | -937M | -744M | -3.21M | -4.29M | -487M | -564M | -389M | -592M | -331M | -541M | -313M | -416M | -274M | -342M |
| Net Change in Cash | -4.23B | 8.75B | 902M | -5.59B | 1.56B | 1.75B | 6.37B | -2.19B | -5.34M | -72.49M | 6.31B | 1.45B | -480M | -2.83B | 2.8B | -8.55B | -7.12B | 12B | 1.81B | -6.65B |
| Free Cash Flow | 10.75B | 3.59B | 5.44B | 4.48B | 10.75B | -2.2B | 1.41B | 2.07B | 72.9M | 7.12M | 13.99B | -921M | 15.93B | 20.16B | 5.95B | -2.04B | 5.09B | 12.86B | -2.1B | -6.79B |
| FCF Margin % | 14.08% | 4.11% | 6.18% | 5.24% | 12.64% | -2.63% | 1.76% | 2.7% | 0.1% | 0.01% | 1680.73% | -1.37% | 2080.86% | 29.78% | 753.32% | -3.9% | 704.69% | 24.17% | -270.62% | -13.79% |
| FCF Growth % | -0.01% | 263.17% | 286.5% | 116.31% | 14645.5% | -30998.76% | -89.94% | 324.97% | -99.54% | -99.96% | 135% | 54.74% | 212.86% | 56.81% | 382.76% | 70.01% | 4383.03% | 65766.55% | -132% | -175.21% |
| FCF per Share | 12.88 | 4.31 | 6.53 | 5.38 | 12.89 | -2.64 | 1.69 | 2.48 | 0.09 | 0.01 | 16.78 | -1.11 | 19.13 | 24.23 | 7.16 | -2.45 | 6.12 | 15.46 | -2.53 | -8.16 |
| FCF Conversion (FCF/Net Income) | 6.91x | 0.90x | 1.08x | 1.03x | 1.38x | 0.47x | 0.74x | 0.61x | 0.01x | 0.00x | 100.14x | 0.80x | 168.72x | 1.87x | 66.56x | 0.56x | 784.14x | 2.45x | 38.14x | -0.60x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |